Health, 09.08.2019 21:10 joydivision01
A46-year-old man is currently enrolled in a phase 2 study of a drug for severe diabetic neuropathy. while the study is on-going, a new drug becomes commercially available that may have equal or greater benefit to the subject. the investigator should do which of the following?
(a) tell the subject about the new drug but discourage him from switching treatment until the study is completed.
(b) withhold this information to avoid confusing the subject with other treatment options or alternatives.
(c) give the subject comprehensive information about the new drug, including its side effects, discuss the pros and cons of both investigational drug and commercially available drug and then allow the subject to decide whether to withdraw from the research to take the new drug.
(d) dont tell the subject about the new drug since phycian have the right to try our new treatments with their new patients.
Answers: 2
Health, 22.06.2019 18:30, webbhlharryteach
The correct serving size for a complete protein is the size of your fingers. true false
Answers: 2
Health, 23.06.2019 05:10, putaprincess16
Aclient is prescribed digoxin (lanoxin). what are contraindications/precautions for the use of digoxin (lanoxin)?
Answers: 1
Health, 23.06.2019 07:30, sjackson0625p8w1a0
Recognizing your emotions is an important first step toward a. dealing with them in a healthy way b. acting on them immediately c. using defense mechanisms to deal with them d. denying that they exist
Answers: 2
A46-year-old man is currently enrolled in a phase 2 study of a drug for severe diabetic neuropathy....
Mathematics, 22.02.2021 23:20
Mathematics, 22.02.2021 23:20
Mathematics, 22.02.2021 23:20
Mathematics, 22.02.2021 23:20
English, 22.02.2021 23:20
Mathematics, 22.02.2021 23:20